Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Awad G Abdellatif"'
Autor:
Abdulkader H El-Debani, Fadya A Menesi, Saleh E Mghil, Mustafa Y.G. Younis, Ghazala Othman, Fathi M Sherif, Awad G Abdellatif, Isam Denna, Faraj El Shari, Mabroka A El Majdob
Publikováno v:
International Journal of Pharmaceutical Sciences and Developmental Research. :017-023
Background: Pulmonary tuberculosis (TB) remains a major global health problem despite the availability of effi cient treatment over the last decades.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ad187d686ca5e3596a1c85bbcacd844
https://doi.org/10.17352/ijpsdr.000011
https://doi.org/10.17352/ijpsdr.000011
Autor:
Awad G Abdellatif, Mustafa Younis Younis, Esam Denna, Safa Elbadri, Ghazala Othman, Fadya A Menesi, Abdulkader H El Debani, Ragab B Roaeid, Faraj El-Shari, Saleh E. Meghil
Publikováno v:
Ibnosina Journal of Medicine and Biomedical Sciences. :73-80
A group of patients with increased diabetes andhyperlipidemia were divided into male and female groupsand further subdivided into 3 groups. These groupsreceived, either simvastatin (20 mg daily), Omega3-fattyacid (2g/day), or both. The blood pressure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34bcf9adb9f1bb12fc339785f749fd94
https://doi.org/10.4103/1947-489x.210220
https://doi.org/10.4103/1947-489x.210220
Autor:
Fadya A Menesi, Fathi M Sherif, Maha ElGharadwi, Abdelkader H. El-Debani, Faraj El-Shari, Awad G Abdellatif, Esamm El-Denna, Mustfa Y Younis, Saleh Mursi, Ghazala Othman
Publikováno v:
Pharmacy & Pharmacology International Journal. 5
Type 2 of diabetes mellitus (DM) is associated with progressive failure of pancreatic B-cells to secrete insulin, decreased insulin action, due to reduced insulin receptors at the target sites. Dyslipidemia is a common risk of DM and is responsible t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bdef148cec606f9b1dfeb1ce1e6f3843
https://doi.org/10.15406/ppij.2017.05.00116
https://doi.org/10.15406/ppij.2017.05.00116
Autor:
Marcel Roberfroid, Ahmad H. Al-Tonsy, M. Nezam Ullah Khan, Mahmoud E. Awad, Awad G. Abdellatif
Publikováno v:
Disease Markers
Disease Markers, Vol 19, Iss 1, Pp 19-25 (2003)
Disease Markers, Vol 19, Iss 1, Pp 19-25 (2003)
Although peroxisome proliferators are considered non-genotoxic agents, most of them, nevertheless, were found to promote and/or induce, hepatocellular carcinoma (HCC) in rodents. The aim of the present study is, first, to investigate whether the pero
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::302a57c30d4ee402ff6276cc745ec386
https://doi.org/10.1155/2003/135859
https://doi.org/10.1155/2003/135859
Publikováno v:
Toxicology and Applied Pharmacology. 111:530-537
Perfluorooctanoic acid (PFOA) is a peroxisome proliferator. The aim of this study was to test for its ability to act as a positive modulator of hepatocarcinogenesis, in the so-called biphasic (initiation by diethylnitrosamine 200 mg/kg ip followed by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f435adbc6a8967c893120b6a992de60
https://doi.org/10.1016/0041-008x(91)90257-f
https://doi.org/10.1016/0041-008x(91)90257-f
Publikováno v:
Carcinogenesis. 11:1899-1902
Using an initiation--selection--promotion protocol for induction of liver tumors in Wistar rats, the modulating action of various peroxisome proliferators on neoplasia as well as on selected biochemical parameters was studied. After treatment with di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7b0b4556ab5d4970fb8f3f41cc92654
https://doi.org/10.1093/carcin/11.11.1899
https://doi.org/10.1093/carcin/11.11.1899